170 related articles for article (PubMed ID: 24937966)
1. Falling estradiol levels on day after human chorionic gonadotropin administration in assisted reproductive technology cycles are not predictive of decreasing oocyte maturity or pregnancy rates.
Levy G; Hill M; Beall S; Pilgrim JD; Payson M; Propst A
J Reprod Med; 2014; 59(5-6):255-9. PubMed ID: 24937966
[TBL] [Abstract][Full Text] [Related]
2. Association of serum estradiol levels on the day of hCG administration with pregnancy rates and embryo scores in fresh ICSI/ET cycles down regulated with either GnRH agonists or GnRH antagonists.
Taşkin EA; Atabekoğlu CS; Musali N; Öztuna D; Sönmezer M
Arch Gynecol Obstet; 2014 Feb; 289(2):399-405. PubMed ID: 23912535
[TBL] [Abstract][Full Text] [Related]
3. High estradiol levels and high oocyte yield are not detrimental to in vitro fertilization outcome.
Sharara FI; McClamrock HD
Fertil Steril; 1999 Sep; 72(3):401-5. PubMed ID: 10519607
[TBL] [Abstract][Full Text] [Related]
4. Serum estradiol level change after human chorionic gonadotropin administration had no correlation with live birth rate in IVF cycles.
Huang R; Fang C; Wang N; Li L; Yi Y; Liang X
Eur J Obstet Gynecol Reprod Biol; 2014 Jul; 178():177-82. PubMed ID: 24862918
[TBL] [Abstract][Full Text] [Related]
5. Can in vitro fertilization cycles be salvaged by repeat administration of intramuscular human chorionic gonadotropin the day after failed injection?
Reichman DE; Greenwood E; Meyer L; Kligman I; Rosenwaks Z
Fertil Steril; 2012 Sep; 98(3):671-4. PubMed ID: 22769734
[TBL] [Abstract][Full Text] [Related]
6. Relationship between the oestradiol/oocyte ratio and the outcome of assisted reproductive technology cycles with gonadotropin releasing hormone agonist.
Var T; Tonguc E; Dogan M; Mollamahmutoglu L
Gynecol Endocrinol; 2011 Aug; 27(8):558-61. PubMed ID: 20642381
[TBL] [Abstract][Full Text] [Related]
7. Should progesterone on the human chorionic gonadotropin day still be measured?
Martinez F; Rodriguez I; Devesa M; Buxaderas R; Gómez MJ; Coroleu B
Fertil Steril; 2016 Jan; 105(1):86-92. PubMed ID: 26453983
[TBL] [Abstract][Full Text] [Related]
8. Dual trigger with combination of gonadotropin-releasing hormone agonist and human chorionic gonadotropin significantly improves the live-birth rate for normal responders in GnRH-antagonist cycles.
Lin MH; Wu FS; Lee RK; Li SH; Lin SY; Hwu YM
Fertil Steril; 2013 Nov; 100(5):1296-302. PubMed ID: 23993928
[TBL] [Abstract][Full Text] [Related]
9. Lag time from ovulation trigger to oocyte aspiration and oocyte maturity in assisted reproductive technology cycles: a retrospective study.
Weiss A; Neril R; Geslevich J; Lavee M; Beck-Fruchter R; Golan J; Shalev E
Fertil Steril; 2014 Aug; 102(2):419-23. PubMed ID: 24880653
[TBL] [Abstract][Full Text] [Related]
10. High Serum FSH is Associated with Brown Oocyte Formation and a Lower Pregnacy Rate in Human IVF Parctice.
Xu H; Deng K; Luo Q; Chen J; Zhang X; Wang X; Diao H; Zhang C
Cell Physiol Biochem; 2016; 39(2):677-84. PubMed ID: 27442586
[TBL] [Abstract][Full Text] [Related]
11. Gonadotropin-releasing hormone agonist or human chorionic gonadotropin for final oocyte maturation in an oocyte donor program.
Erb TM; Vitek W; Wakim AN
Fertil Steril; 2010 Feb; 93(2):374-8. PubMed ID: 19171336
[TBL] [Abstract][Full Text] [Related]
12. Progesterone/estradiol ratio <0.25 on the day of human chorionic gonadotropin administration is associated with adverse pregnancy outcomes in prolonged protocols for in vitro fertilization/intracytoplasmic sperm injection.
Li Y; Luo K; Tang Y; Lin G; Lu G; Gong F
Taiwan J Obstet Gynecol; 2017 Feb; 56(1):27-31. PubMed ID: 28254221
[TBL] [Abstract][Full Text] [Related]
13. Dual trigger with gonadotropin-releasing hormone agonist and standard dose human chorionic gonadotropin to improve oocyte maturity rates.
Griffin D; Feinn R; Engmann L; Nulsen J; Budinetz T; Benadiva C
Fertil Steril; 2014 Aug; 102(2):405-9. PubMed ID: 24842671
[TBL] [Abstract][Full Text] [Related]
14. [Serum estradiol the day of hCG administration as predictor factor of IVF-ET].
Kably Ambe A; Estévez González S; Carballo Mondragón E
Ginecol Obstet Mex; 2008 Apr; 76(4):197-201. PubMed ID: 18798418
[TBL] [Abstract][Full Text] [Related]
15. 1,500 IU human chorionic gonadotropin administered at oocyte retrieval rescues the luteal phase when gonadotropin-releasing hormone agonist is used for ovulation induction: a prospective, randomized, controlled study.
Humaidan P; Ejdrup Bredkjaer H; Westergaard LG; Yding Andersen C
Fertil Steril; 2010 Feb; 93(3):847-54. PubMed ID: 19200959
[TBL] [Abstract][Full Text] [Related]
16. A moderately extended time interval between hCG administration and oocyte retrieval is good for most patients with oocyte retrieval scheduled on the same day: a retrospective cohort study.
Deng M; Liang Y; Qin H; Tan Y; Mai Q; Yuan X; Yuan Y
J Obstet Gynaecol; 2020 Oct; 40(7):1006-1011. PubMed ID: 31790622
[TBL] [Abstract][Full Text] [Related]
17. Supraphysiological estradiol levels do not affect oocyte and embryo quality in oocyte donation cycles.
Peña JE; Chang PL; Chan LK; Zeitoun K; Thornton MH; Sauer MV
Hum Reprod; 2002 Jan; 17(1):83-7. PubMed ID: 11756366
[TBL] [Abstract][Full Text] [Related]
18. Early luteal phase endocrine profile is affected by the mode of triggering final oocyte maturation and the luteal phase support used in recombinant follicle-stimulating hormone-gonadotropin-releasing hormone antagonist in vitro fertilization cycles.
Fatemi HM; Polyzos NP; van Vaerenbergh I; Bourgain C; Blockeel C; Alsbjerg B; Papanikolaou EG; Humaidan P
Fertil Steril; 2013 Sep; 100(3):742-7. PubMed ID: 23806846
[TBL] [Abstract][Full Text] [Related]
19. Serum human chorionic gonadotropin levels are correlated with body mass index rather than route of administration in women undergoing in vitro fertilization--embryo transfer using human menopausal gonadotropin and intracytoplasmic sperm injection.
Elkind-Hirsch KE; Bello S; Esparcia L; Phillips K; Sheiko A; McNichol M
Fertil Steril; 2001 Apr; 75(4):700-4. PubMed ID: 11287022
[TBL] [Abstract][Full Text] [Related]
20. A decrease in serum estradiol levels after human chorionic gonadotrophin administration predicts significantly lower clinical pregnancy and live birth rates in in vitro fertilization cycles.
Kondapalli LA; Molinaro TA; Sammel MD; Dokras A
Hum Reprod; 2012 Sep; 27(9):2690-7. PubMed ID: 22752608
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
